头颈癌幸存者放疗后原发性甲状腺功能减退NTCP模型的多中心外部验证
该多中心研究系统检索已发表的正常组织并发症概率(NTCP)模型,并在4个肿瘤中心1054例接受调强放疗的头颈癌患者中外部验证10个模型。8年随访时模型准确度0.551–0.645、AUC 0.577–0.748,校准斜率均<1且截距为正。纳入甲状腺平均剂量和甲状腺储备指标(甲状腺体积或基线TSH)的模型校准与区分度更优。
要点
- 现有NTCP模型对头颈癌放疗后甲状腺功能减退的长期预测存在校准偏差,尤其在高、低预测概率端。
- 包含甲状腺平均剂量及甲状腺体积或基线TSH的模型区分度与校准更优。
- 表现满意的模型在阈值概率0.30–0.90区间决策曲线分析显示净获益。
核心结论
- 这是迄今规模最大的放疗诱导甲状腺功能减退预测模型外部验证,当前模型对长期风险的校准可能存在偏差,尤其在高、低预测概率端。
- 纳入甲状腺平均剂量和甲状腺储备替代指标的模型表现满意,有望指导个体化放疗计划。
研究设计与样本
- 系统文献检索识别已发表的NTCP模型和列线图,使用4个肿瘤中心1054例接受调强放疗的头颈癌患者多中心队列进行外部验证。
- 原发性甲状腺功能减退定义为血清促甲状腺激素(TSH)水平高于正常上限。
- 采用竞争风险分析(死亡为竞争事件)估计累积发生率,并应用逆概率删失加权处理信息性失访。
主要发现
- 共识别10个候选NTCP模型或列线图进行外部验证。
- 8年随访时模型准确度范围0.551–0.645,受试者工作特征曲线下面积(AUC)范围0.577–0.748。
- 所有模型校准斜率<1且校准截距为正。
- 纳入甲状腺平均剂量和甲状腺功能储备指标(如甲状腺体积或基线TSH水平)的模型校准和区分度更优。
关键数值与推荐
- 原发性甲状腺功能减退定义:血清TSH水平超过正常上限。
- 表现满意的模型在阈值概率0.30–0.90区间决策曲线分析显示优于全治或全不治策略的净获益。
临床怎么用
- 临床医生应意识到当前模型对长期甲状腺功能减退风险的预测可能存在校准偏差,尤其在高、低预测概率端。
- 优先考虑包含甲状腺平均剂量和甲状腺储备替代指标(甲状腺体积或基线TSH)的模型用于个体化放疗计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Numerous normal tissue complication probability (NTCP) models have been developed to predict radiation-induced primary hypothyroidism, but their external validity and clinical applicability remain unclear. This multicenter study aimed to externally validate and compare published NTCP models using long-term endocrine outcomes and assess their predictive performance and clinical utility. METHODS AND MATERIALS: A comprehensive systematic literature search was carried out to identify published NTCP models and nomograms for hypothyroidism prediction. External validation was performed using a multicenter cohort of 1054 patients with head and neck cancer treated with intensity modulated radiation therapy at 4 oncology centers. Primary hypothyroidism was defined as an elevated serum thyroid-stimulating hormone level exceeding the upper limit of normal. Clinical data and radiation dose-volume parameters of the thyroid gland were extracted. The cumulative incidence of hypothyroidism was estimated using competing risk analysis with death as a competing event, applying inverse probability of censoring weighting to account for informative loss to follow-up. Model predictive performance was compared using multiple metrics, including accuracy, discrimination, calibration curves, and the Brier score. Decision curve analyses were conducted to evaluate clinical utility. RESULTS: Ten candidate NTCP models or nomograms were identified for external validation. Model performance varied, with accuracy ranging from 0.551 to 0.645 and area under the receiver operating characteristic curve ranging from 0.577 to 0.748 at 8 years of follow-up. Calibration slopes were <1, and calibration intercepts were positive across all models. Models incorporating thyroid mean dose and thyroid function reserve metrics, such as thyroid volume or baseline thyroid-stimulating hormone level, demonstrated superior calibration and discrimination. For models with satisfactory performance, decision curve analysis indicated a net benefit over treat-all or treat-none strategies across threshold probabilities between 0.30 and 0.90. CONCLUSIONS: This study represents the largest external validation of prediction models for radiation-induced hypothyroidism to date. Clinicians should be aware of the potential miscalibration of long-term hypothyroidism risk by current models, particularly at the extreme ends of predicted probabilities. Models that incorporated thyroid mean dose and surrogates of thyroid reserve demonstrated satisfactory performance and showed promise for guiding personalized radiation therapy planning.
引用
- Chow JCH, Wong KCW, Cai J, et al. Multicenter External Validation of Normal Tissue Complication Probability Models for Radiation-Induced Primary Hypothyroidism in Head and Neck Cancer Survivors With Long-Term Endocrine Outcomes. Int J Radiat Oncol Biol Phys. 2026. PMID: 42409271. doi:10.1016/j.ijrobp.2026.06.3077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。